Seeing Is Believing
Currently out of the existing stock ratings of Shaunak Deepak, 9 are a BUY (100%).
Analyst Shaunak Deepak, carries an average stock price target met ratio of 50% that have a potential upside of 49.43% achieved within 1211 days. Previously, Shaunak Deepak worked at HC WAINWRIGHT, JEFFERIES, AVONDALE.
Shaunak Deepak’s has documented 17 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on KPTI, Karyopharm Therapeutics at 17-Mar-2017.
Analyst best performing recommendations are on KPTI (KARYOPHARM THERAPEUTICS).
The best stock recommendation documented was for KPTI (KARYOPHARM THERAPEUTICS) at 8/18/2016. The price target of $225 was fulfilled within 560 days with a profit of $108.15 (92.55%) receiving and performance score of 1.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Feb-2026
$13
$9.2 (242.11%)
$14
1 months 27 days ago
(06-Aug-2026)
0/6 (0%)
$9.11 (234.19%)
Buy Since 25-Oct-2019
$10
$5.86 (141.55%)
$8
4 months 26 days ago
(07-May-2026)
5/14 (35.71%)
$6.45 (181.69%)
760
Buy Since 10-Apr-2025
$7
$2.86 (69.08%)
$8
4 months 26 days ago
(07-May-2026)
0/4 (0%)
$3.45 (97.18%)
Hold Since 07-May-2026
$4.75
$0.61 (14.73%)
$3.5
4 months 26 days ago
(07-May-2026)
1/6 (16.67%)
$1.2 (33.80%)
68
Buy Since 07-Jul-2025
$8
$4.2 (110.53%)
$11
6 months 28 days ago
(05-Mar-2026)
0/3 (0%)
$5.17 (182.69%)